期刊文献+

血浆miR-221在急性髓细胞白血病中的表达及意义 被引量:1

The expression and significance of plasma miR-221 in the acute myeloid leukemia
下载PDF
导出
摘要 目的:探讨血浆miR-221在急性髓细胞白血病(acute myeloid leukemia,AML)中的表达及意义。方法:收集38例成人AML患者,其中初发患者12例(M21例,M33例,M46例,M52例),复发患者8例(M22例,M33例,M42例,M51例),完全缓解(complete remission,CR)患者18例(M22例,M36例,M46例,M54例)及3例正常人的外周血血浆标本。采用基于SYBR Green荧光染料法的茎环实时定量PCR(qRT-PCR),以U6为内参照,用2(-△Ct)方法计算miR-221的相对表达量,分析血浆miR-221的表达情况。结果:qRT-PCR结果显示,较之CR组和正常对照组,AML初发组和复发组中血浆miR-221的表达量明显升高,差异均有显著性(P<0.05)。初发组和复发组之间无统计学差异(P>0.05)。CR组比正常对照组的表达量高,但两组差异并无统计学意义(P>0.05)。结论:血浆miR-221在AML初发和复发患者中的表达量高,在CR患者及正常对照中的表达量低,提示血浆miR-221与AML肿瘤负荷呈正相关,微创的血浆miRNAs检测可作为临床微小残留病检测的新方法。 Objective To investigate the expression and significance of miR-221 in the plasma of acute myeloid leukemia(AML).Methods Plasma from 12 newly diagnosed,8 relapsed AML patients and 18 complete remission patients were collected.3 healthy persons were tested as normal control.miR-221 expression in AML,CR and NC plasma were analyzed by SYBR Green stem-loop real-time RT-PCR.Results Expression levels of miR-221 were significantly higher in plasma of newly diagnosed and relapsed AML patients than the levels in those of CR patients(P 0.05) and NC(P 0.05).miR-221 expression in CR and NC plasma were not significantly changed(P 0.05).Conclusions miR-221 in plasma may be associated with tumor burden in AML.Detection of plasma miR-221 can be used as a new method in clinical minimal residual disease(MDR).
出处 《实用医学杂志》 CAS 北大核心 2012年第9期1457-1459,共3页 The Journal of Practical Medicine
基金 国家自然科学基金青年科学基金项目(编号:30800486)
关键词 白血病 髓样 血浆 MIR-221 实时定量PCR 微小残留病 Leukemia myeloid Plasma miR-221 Real-time quantitative PCR Minimal residual disease
  • 相关文献

参考文献13

  • 1Lagos-Quintana M, Rauhut R, Lendeekel W, et al. Identification of novel genes coding for small expressed RNAs [J]. Science, 2001,294 (5543) : 853-858.
  • 2Garzon R, Volinia S, Liu C G, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia [J]. Blood, 2008,111(6) :3183-3189.
  • 3Zanette D L, Rivadavia F, Molfetta G A, et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia [J]. Braz J Med Biol Res, 2007,40( 11):1435-1440.
  • 4Garofalo M, Quintavalle C, Romano G, et al. miR221/222 in cancer: their role in tumor progression and response to therapy [J]. Curr Mol Med, 2012,12(1 ) :27-33.
  • 5Li J, Wang Y, Yu W, et al. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance [J]. Biochem Biophys Res Commun, 2011,406(1) :70-73.
  • 6Cammarata G, Augugliaro L, Salemi D, et al. Differential expression of specific microRNA and their targets in acute myeloid leukemia [J]. Am J Hematol, 2010,85(5) :331-339.
  • 7Isken F, Steffen B, Merk S, et al. Identification of acute myeloid leukaemia associated microRNA expression patterns [J]. Br J Haematol, 2008,140(2) : 153-161.
  • 8Shah A A, Leidinger P, Blin N, et al. miRNA: small molecular as potential novel biomarkers in cancer [J]. Curr Med Chem, 2010,17(36) :4427-4432.
  • 9Zheng D, Haddadin S, Wang Y, et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer[J]. Int J Clin Exp Pathol, 2011,4(6):575-586.
  • 10Chen C, Ridzon D A, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR [J]. Nucleic Acids Res, 2005,33 (20) : e 179.

同被引文献20

  • 1Guo K, Yang Y, Qiu J, et al. The expression profile ofmicroRNAs in wistar rats with lipopolysaccharide-induced periventricular leukomalacia[J]. J Mol Neurosci, 2013, 51(3): 941-949.
  • 2Srinivasan S, Selvan ST, Archunan G, et al. MicroRNAs -the next generation therapeutic targets in human diseases [J]. Theranostics, 2013,3(12): 930-942.
  • 3Xi Y. MicroRNA: A New Player for Cancer Chemoprevention[J]. J Integr Oncol, 2013, 2(1): 105.
  • 4Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers [J]. Med Res Rev, 2012, 32(2): 326-348.
  • 5Zou J, Li WQ, Li Q, et al. Two functional microRNA-126s repress a novel target gene p21-activated kinase 1 to regulate vascular integrity in zebrafish[J]. Circ Res, 2011,108(2): 201-209.
  • 6Bradl M, Lassmann H. Oligodendrocytes: biology and pathology [J]. Acta Neuropathol, 2010,119(1): 37-53.
  • 7Back SA. Cerebral White and Gray Matter Injury in Newborns: New Insights into Pathophysiology and Management [J]. Clin Perinatol, 2014, 41(1): 1-24.
  • 8Dugas JC, Cuellar TL, Scholze A, et al. Dicer! and miR-219 Are required for normal oligodendrocyte differentiation and myelination[J]. Neuron, 2010, 65(5): 597-611.
  • 9Zhao X, He X, Han X, et al. MicroRNA-mediated control of oligodendrocyte differentiation[J]. Neuron, 2010, 65(5): 612-626.
  • 10Zucchi FC, Yao Y, Ward ID, et al. Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring[J]. PLoS One, 2013, 8(2): e56967.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部